The battle over drug cost disclosure is heating up.  Last month, the federal government posted a RFP on its website to locate a firm capable of surveying and determining nationwide drug costs.  Apparently, CMS wants to create publicly available pricing databases on a monthly basis that would reveal the actual costs of drugs.  Imagine that!

As reflected in an article in Drug Benefit News, industry stakeholders are again mounting an attack to prevent cost information from being publicly disclosed.

Were CMS to overcome all odds — and be successful in publishing cost information — state Medicaid programs and commercial payers would finally have an easier means for determining the extent to which they are overpaying for drugs.  Until that occurs, Pharmacy Benefit Consultants will continue to provide our clients with claims data “X-Rays” to help our clients assess the competitiveness of their costs.